Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing

Abstract

Background DNA methylation changes with age. Chronological age predictors built from DNA methylation are termed ‘epigenetic clocks’. The deviation of predicted age from the actual age (‘age acceleration residual’, AAR) has been reported to be associated with death. However, it is currently unclear how a better prediction of chronological age affects such association. Methods In this study, we build multiple predictors based on training DNA methylation samples selected from 13,661 samples (13,402 from blood and 259 from saliva). We use the Lothian Birth Cohorts of 1921 (LBC1921) and 1936 (LBC1936) to examine whether the association between AAR (from these predictors) and death is affected by (1) improving prediction accuracy of an age predictor as its training sample size increases (from 335 to 12,710) and (2) additionally correcting for confounders (i.e., cellular compositions). In addition, we investigated the performance of our predictor in non-blood tissues. Results We found that in principle, a near-perfect age predictor could be developed when the training sample size is sufficiently large. The association between AAR and mortality attenuates as prediction accuracy increases. AAR from our best predictor (based on Elastic Net, https://github.com/qzhang314/DNAm-based-age-predictor ) exhibits no association with mortality in both LBC1921 (hazard ratio = 1.08, 95% CI 0.91–1.27) and LBC1936 (hazard ratio = 1.00, 95% CI 0.79–1.28). Predictors based on small sample size are prone to confounding by cellular compositions relative to those from large sample size. We observed comparable performance of our predictor in non-blood tissues with a multi-tissue-based predictor. Conclusions This study indicates that the epigenetic clock can be improved by increasing the training sample size and that its association with mortality attenuates with increased prediction of chronological age. Electronic supplementary material The online version of this article (10.1186/s13073-019-0667-1) contains supplementary material, which is available to authorized users.

Analysis of DNA methylation associates the cystine–glutamate antiporter SLC7A11 with risk of Parkinson’s disease

“…Prior to association analyses we regressed DNA methylation measures on known batch effects, which included sentrix row, column and slide in SGPD, and sentrix row and column only in PEG, because slide was significantly associated with disease status in that sample. Sex, predicted age 55 , predicted smoking exposure (unpublished work) and predicted CTPs (with the exception of eosinophils) were fitted as fixed effects. We checked strongly associated probes for the presence of common SNPs, using the masking manifests provided by Illumina (https://zwdzwd.github.io/InfiniumAnnotation).…”

Significant out-of-sample classification from methylation profile scoring for amyotrophic lateral sclerosis

“…Written consent was obtained from all individuals enrolled in this study, and the study was approved by the corresponding HREC at the different sites: University of Sydney, Western Sydney Local Health District, Royal Brisbane and Women Hospital Metro North, South Metropolitan Health Service, Macquarie University, QIMR Berghofer Medical Research Institute, University of New South Wales and the University of Melbourne. The mean predicted age, 40 predicted smoking scores, 29 and sex distribution between cases and controls for the cohorts used in this study can be found in Supplementary Table 5.…”

Association of 4 epigenetic clocks with measures of functional health, cognition, and all-cause mortality in The Irish Longitudinal Study on Ageing (TILDA)

“…In a wide-ranging review describing the development and evolution of the epigenetic clocks, Horvath & Raj 5 acknowledged that the first-generation clocks exhibited only weak associations with clinical measures of physiological dysregulation such as blood pressure or glucose metabolism that anticipate hard disease end-points. Recently, Zhang et al 8 have shown that, in principle, a near perfect predictor of calendar age can be estimated from DNA methylation levels, but its association with mortality attenuates with increased accuracy in predicting calendar age; the logical corollary of which is that the training sets being used for deriving accurate biological age estimators require more for their calibration than simply calendar age. The second-generation clocks, PhenoAge 9 and GrimAge 10 were designed to overcome these limitations by including DNAm correlates of morbidity and mortality.…”